Until now, the diagnostic and prognostic values of most circulating biomarkers (including D-dimers and MPO) have been determined in comparison with healthy controls, with groups selected for age and sex (screening programmes), or selected for specific vascular diseases (such as PAD) [8,10,14,16,18,19]. The gene discussed is MPO; the disease is peripheral arterial disease.